These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8751535)

  • 1. The benefit of heparin-bound circuits.
    Moulijn AC; Amsel BJ
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):557-8. PubMed ID: 8751535
    [No Abstract]   [Full Text] [Related]  

  • 2. Issues of biocompatibility: heparin-coated extracorporeal circuit.
    Hsu LC
    Int Anesthesiol Clin; 1996; 34(2):109-22. PubMed ID: 8799749
    [No Abstract]   [Full Text] [Related]  

  • 3. [Activation of blood coagulation in extracorporeal circulation].
    Nowak G
    Wien Klin Wochenschr; 1996; 108 Suppl 1():9-14. PubMed ID: 8686324
    [No Abstract]   [Full Text] [Related]  

  • 4. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
    Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomaterial-dependent blood activation during simulated extracorporeal circulation: a study of heparin-coated and uncoated circuits.
    Borowiec JW; Venge P; Henze A; Nilsson B; Stiernström H
    Thorac Cardiovasc Surg; 1997 Dec; 45(6):295-301. PubMed ID: 9477462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRECiSe (priming reduced extracorporeal circulation setup): results of a safety study.
    Beholz S; Kessler M; Konertz WF
    Heart Surg Forum; 2003; 6(5):311-5. PubMed ID: 14721800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Heparin concentration and hemostatic alterations with low systemic heparinization during CPB using heparin-coated circuits].
    Yoshie M; Hirose Y; Gamo M; Matsuo K
    Masui; 2001 Feb; 50(2):179-83. PubMed ID: 11244775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An ex vivo evaluation of blood coagulation and thromboresistance of two extracorporeal circuit coatings with reduced and full heparin dose.
    Teligui L; Dalmayrac E; Mabilleau G; Macchi L; Godon A; Corbeau JJ; Denommé AS; Bouquet E; Boer C; Baufreton C
    Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):763-9. PubMed ID: 24632424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A unified method for regional anticoagulation of blood.
    Durie MD; Hansebout RR; Peterson EW; Ringer TR
    Am J Surg; 1970 Sep; 120(3):341-5. PubMed ID: 5456917
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombogenicity is not reduced when heparin and phospholipid bonded circuits are used in a rabbit model of extracorporeal circulation.
    Meinhardt JP; Annich GM; Miskulin J; Kawai T; Ashton BA; Bartlett RH
    ASAIO J; 2003; 49(4):395-400. PubMed ID: 12918580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of bound heparin in prolonged extracorporeal membrane oxygenation.
    Toomasian JM; Zwischenberger JB; Oram AD; DeSmet GM; Bartlett RH
    Trans Am Soc Artif Intern Organs; 1984; 30():133-6. PubMed ID: 6533877
    [No Abstract]   [Full Text] [Related]  

  • 12. Biocompatibility reflected by haemostasis variables during cardiopulmonary bypass using heparin-coated circuits.
    Borowiec J; Bagge L; Saldeen T; Thelin S
    Thorac Cardiovasc Surg; 1997 Aug; 45(4):163-7. PubMed ID: 9323816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using an intravascular device to reverse refractory burn-associated hypothermia.
    Karabinis A; Mandila C; Koukoulitsios G; Dounis G; Tsoutsos D
    Anaesth Intensive Care; 2008 Nov; 36(6):918-9. PubMed ID: 19117092
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombin generation with heparin-bonded cardiopulmonary bypass circuits.
    Bannan S; Martin PG
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):849. PubMed ID: 8800182
    [No Abstract]   [Full Text] [Related]  

  • 15. [Heparin-protamine-protocol].
    Nomoto S
    Nihon Geka Hokan; 1997 May; 66(2):49-50. PubMed ID: 9796248
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticoagulation with prostaglandins during extracorporeal circulation.
    Kozek-Langenecker SA
    Wien Klin Wochenschr; 1999 Feb; 111(4):129-40. PubMed ID: 10192145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in coagulation, fibrinolysis and platelet functions during extracorporeal circulation].
    Kaizu K; Uriu K; Ikeda M
    Nihon Rinsho; 2004 May; 62 Suppl 5():46-9. PubMed ID: 15197886
    [No Abstract]   [Full Text] [Related]  

  • 18. Improving cardiopulmonary bypass: heparin-coated circuits.
    Vocelka C; Lindley G
    J Extra Corpor Technol; 2003 Dec; 35(4):312-6. PubMed ID: 14979422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of surface-bound and intravenously administered heparin on cell-surface interactions: inflammation and coagulation.
    Johnson G; Curry B; Cahalan L; Prater R; Biggerstaff J; Hussain A; Gartner M; Cahalan P
    Perfusion; 2013 May; 28(3):263-71. PubMed ID: 23401339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New surface treatments to prevent thrombosis during extracorporeal circulation.
    Splittgerber FH; Whittlesey GC; Klein MD
    Trans Am Soc Artif Intern Organs; 1985; 31():474-8. PubMed ID: 3837492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.